UroMems Raises $60 Million for UroActive System Development
UroMems has secured a $60 million strategic investment from Ajax Health Fund I to support clinical trials and the commercial launch of its UroActive® System, the first smart automated implant for treating stress urinary incontinence (SUI). This funding will aid in pivotal clinical trials in the U.S. and France, leading to regulatory submissions. The investment builds on previous financing and aims to position UroActive as a leading treatment option for SUI, which affects millions globally.
Capital will continue funding pivotal clinical trials and commercial launch preparation of the UroActive® System, the first smart automated implant to treat stress urinary incontinence GRENOBLE, France and MINNEAPOLIS, May 13, 2026 /PRNewswire/ — UroMems, a global company developing…